Cyclic AMP concentrations in dendritic cells induce and regulate Th2 immunity and allergic asthma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 5, 2015, Pages 1529-1534

  Lee, Jihyung ^a   Kim, Tae Hoon ^a,b   Murray, Fiona ^a,c   Li, Xiangli ^a   Choi, Sara S ^a   Broide, David H ^a   Corr, Maripat ^a   Lee, Jongdae ^a   Webster, Nicholas J G ^a,d   Insel, Paul A ^a,e   Raz, Eyal ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Korea University College of Medicine   (South Korea)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; GNAS PROTEIN, MOUSE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; GENE ACTIVATION; GENE DELETION; GENE INDUCTION; IMMUNITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TH2 CELL; ADOPTIVE TRANSFER; ANIMAL; ASTHMA; CYTOLOGY; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM;

MUS;

ADOPTIVE TRANSFER; ANIMALS; ASTHMA; CYCLIC AMP; DENDRITIC CELLS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HYPERSENSITIVITY; MICE; TH2 CELLS;

EID: 84922309110     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1417972112     Document Type: Article

References (52)

1. Pulendran B, Artis D (2012) New paradigms in type 2 immunity. Science 337(6093):431-435.
2. Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations (∗). Annu Rev Immunol 28:445-489.
3. Kim HY, DeKruyff RH, Umetsu DT (2010) The many paths to asthma: Phenotype shaped by innate and adaptive immunity. Nat Immunol 11(7):577-584.
4. Paul WE, Zhu J (2010) How are T(H)2-type immune responses initiated and amplified?Nat Rev Immunol 10(4):225-235.
5. Saenz SA, Noti M, Artis D (2010) Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. Trends Immunol 31(11):407-413.
6. Ohnmacht C, et al. (2010) Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. Immunity 33(3):364-374.
7. Voehringer D (2013) Protective and pathological roles of mast cells and basophils. Nat Rev Immunol 13(5):362-375.
8. Holgate ST (2012) Innate and adaptive immune responses in asthma. Nat Med 18(5):673-683.
9. Halim TY, et al. (2014) Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40(3):425-435.
10. Hoyler T, et al. (2012) The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37(4):634-648.
11. Gause WC, Wynn TA, Allen JE (2013) Type 2 immunity and wound healing: Evolutionary refinement of adaptive immunity by helminths. Nat Rev Immunol 13(8):607-614.
12. Okamoto M, et al. (2009) Jagged1 on dendritic cells and Notch on CD4+ T cells initiate lung allergic responsiveness by inducing IL-4 production. J Immunol 183(5):2995-3003.
13. Wang YH, Liu YJ (2007) OX40-OX40L interactions: A promising therapeutic target for allergic diseases? J Clin Invest 117(12):3655-3657.
14. Schett G, Sloan VS, Stevens RM, Schafer P (2010) Apremilast: A novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases. Ther Adv Musculoskelet Dis 2(5):271-278.
15. Heystek HC, Thierry AC, Soulard P, Moulon C (2003) Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity. Int Immunol 15(7):827-835.
16. Datta SK, et al. (2010) Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax. Proc Natl Acad Sci USA 107(23):10638-10643.
17. Adams GB, et al. (2009) Haematopoietic stem cells depend on Galpha(s)-mediated signalling to engraft bone marrow. Nature 459(7243):103-107.
18. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383(6603):787-793.
19. Lambrecht BN, Hammad H (2014) The immunology of asthma. Nat Immunol 16(1):45-56.
20. Mosenden R, Taskén K (2011) Cyclic AMP-mediated immune regulation - overview of mechanisms of action in T cells. Cell Signal 23(6):1009-1016.
21. Li X, et al. (2012) Divergent requirement for Gαs and cAMP in the differentiation and inflammatory profile of distinct mouse Th subsets. J Clin Invest 122(3):963-973.
22. Hayashi T, et al. (2007) 3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis. Proc Natl Acad Sci USA 104(47):18619-18624.
23. Merad M, Sathe P, Helft J, Miller J, Mortha A (2013) The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31:563-604.
24. Hammer GE, Ma A (2013) Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu Rev Immunol 31:743-791.
25. Löhning M, et al. (1998) T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 95(12):6930-6935.
26. Hammad H, et al. (2010) Inflammatory dendritic cells - not basophils - are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med 207(10):2097-2111.
27. Shortman K, Naik SH (2007) Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7(1):19-30.
28. Mohrs M, Shinkai K, Mohrs K, Locksley RM (2001) Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 15(2):303-311.
29. McDonald F, Mohrs M, Brewer J (2006) Using bicistronic IL-4 reporter mice to identify IL-4 expressing cells following immunisation with aluminium adjuvant. Vaccine 24(26):5393-5399.
30. Lin CH, Tzen JT, Shyu CL, Yang MJ, Tu WC (2011) Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. Peptides 32(10):2027-2036.
31. Jones S, Howl J (2006) Biological applications of the receptor mimetic peptide mastoparan. Curr Protein Pept Sci 7(6):501-508.
32. Arima M, Fukuda T (2011) Prostaglandin D2 and T(H)2 inflammation in the pathogenesis of bronchial asthma. Korean J Intern Med 26(1):8-18.
33. Elhofy A, et al. (2005) Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis. J Leukoc Biol 77(2):229-237.
34. Lambrecht BN, Hammad H (2012) Lung dendritic cells in respiratory viral infection and asthma: From protection to immunopathology. Annu Rev Immunol 30:243-270.
35. Steinman RM (2012) Decisions about dendritic cells: Past, present, and future. Annu Rev Immunol 30:1-22.
36. Joffre O, Nolte MA, Spörri R, Reis e Sousa C (2009) Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev 227(1):234-247.
37. Akira S (2011) Innate immunity and adjuvants. Philos Trans R Soc Lond B Biol Sci 366(1579):2748-2755.
38. Oliphant CJ, et al. (2014) MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41(2):283-295.
39. Rochlitzer S, et al. (2011) The neuropeptide calcitonin gene-related peptide affects allergic airway inflammation by modulating dendritic cell function. Clin Exp Allergy 41(11):1609-1621.
40. Brown EM, Arrieta MC, Finlay BB (2013) A fresh look at the hygiene hypothesis: How intestinal microbial exposure drives immune effector responses in atopic disease. Semin Immunol 25(5):378-387.
41. Cahenzli J, Köller Y, Wyss M, Geuking MB, McCoy KD (2013) Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. Cell Host Microbe 14(5):559-570.
42. Apter AJ (2013) Advances in adult asthma diagnosis and treatment in 2012: Potential therapeutics and gene-environment interactions. J Allergy Clin Immunol 131(1):47-54.
43. King TP, Jim SY, Wittkowski KM (2003) Inflammatory role of two venom components of yellow jackets (Vespula vulgaris): A mast cell degranulating peptide mastoparan and phospholipase A1. Int Arch Allergy Immunol 131(1):25-32.
44. Fukushima N, et al. (1998) Melittin, a metabostatic peptide inhibiting Gs activity. Peptides 19(5):811-819.
45. Rose CE, Jr, Sung SS, Fu SM (2003) Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10(3-4):273-288.
46. Fajt ML, et al. (2013) Prostaglandin D2 pathway upregulation: Relation to asthma severity, control, and TH2 inflammation. J Allergy Clin Immunol 131(6):1504-1512.
47. Takeda K, Gelfand EW (2009) Mouse models of allergic diseases. Curr Opin Immunol 21(6):660-665.
48. Holmes AM, Solari R, Holgate ST (2011) Animal models of asthma: Value, limitations and opportunities for alternative approaches. Drug Discov Today 16(15-16):659-670.
49. Wenzel S, Holgate ST (2006) The mouse trap: It still yields few answers in asthma. Am J Respir Crit Care Med 174(11):1173-1176, discussion 1176-1178.
50. Pawankar R, Canonica GW, Holgate ST, Lockey RF (2012) Allergic diseases and asthma: A major global health concern. Curr Opin Allergy Clin Immunol 12(1):39-41.
51. Clark NM (2012) Community-based approaches to controlling childhood asthma. Annu Rev Public Health 33:193-208.
52. Akinbami LJ, et al. (2012) Asthma outcomes: Healthcare utilization and costs. J Allergy Clin Immunol 129(3, Suppl):S49-S64